IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation
Zheng Yan(The University of Texas MD Anderson Cancer Center), Kevin D. Houston(New Mexico State University)
Cited by 29
Related Papers
Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation
|Journal of Molecular Endocrinology|2019|9
Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancer
|Frontiers in Endocrinology|2024|1
Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
|Frontiers in Oncology|2024|0
IGFBP-6 regulates breast cancer cell cycle progression by promoting exit out of G1
|Journal of Biological Chemistry|2025|0